Pascal Besman, Chief Operating Officer of PharmaMar, shares a Randomized Trial of Topotecan & CAV | Monotherapy Will Have Up to 100 Patients at Annual Meeting 2018
Randomized Trial of Topotecan & CAV | Monotherapy Will Have Up to 100 Patients
Pascal Besman, Chief Operating Officer of PharmaMar, shares a Randomized Trial of Topotecan & CAV | Monotherapy Will Have Up to 100 Patients at Annual Meeting 2018